WHIPPANY, N.J., July 28, 2015 /PRNewswire/ — Pazoo, Inc. (OTCPink Symbol: PZOO) (German WKN#: A1J3DK) is pleased to announce that wholly-owned subsidiary Harris Lee, LLC has signed a sublicense, and loan agreement with Harris Lee Colorado, LLC (HLC). These agreements now allow HLC to meet the in state residency requirement and provide for the necessary funding to take over the testing lab, expand the marketing and employment base and begin the expansion of the operations.

All agreements will be forwarded on to the Colorado MED for review. A small redesign of the layout of the laboratory will be undertaken to increase the efficiency and functionality of the facility. Over the past 2 months the Pazoo team has made contact with numerous growers and has gotten firm commitments from these growers to test with HLC once the State review is complete. This testing facility currently is using the Steep hill methodology and will continue to utilize this methodology moving forward under the license agreement signed between Harris Lee, LLC and Steep Hill Labs, Inc.

The Denver, Colorado facility is currently certified to provide potency testing.  However, the process has already begun to achieve certification for the additional tests required in Colorado. This already revenue generating facility is expected to quickly expand the number and types of tests currently being conducted.

David Cunic, Co-CEO, states, “We are making the all-important move to a revenue growth stage company. There is a very strong foundation that has been created. We expect the Oregon lease to be finalized soon and we have already garnered strong interest for the products currently being distributed by CannabisKing. I want to thank the patience and support of our shareholders and I can now say with confidence that there is no limit to the success that will be achieved moving forward.” 

ABOUT PAZOO Inc.

Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry-leading laboratory testing of cannabis. Harris Lee’s and MA’s license agreements with Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep Hill’s top-rated testing protocols in select markets as we expand throughout the USA. Pazoo’s subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com.

ABOUT STEEP HILL LABS Inc.

Founded in California in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics. With owned and licensed labs in four U.S. states and plans to add labs in New Mexico, Oregon and possibly Jamaica in 2015, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California – the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™ and GenKit™. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well.

Safe Harbor Statement:

This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates” or other words or phrases of similar import. Similarly, statements herein that describe the Company’s business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.

SOURCE Pazoo, Inc.